Curedm
Get Full AccessDescription
- CureDM, Inc. is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin.The research team at CureDM has discovered and is developing a novel human peptide associated with regeneration of insulin-producing islets within the pancreas. This peptide called Human proIslet Peptide (HIP), also known as Pancreate, stimulates the differentiation of new insulin-producing islets from existing adult pancreatic progenitor cells. Restoration of pancreatic function may be achieved, without the use of stem cells by clinical treatment with this peptide therapeutic. The CureDM approach is to restore, maintain and protect new insulin-producing islet structures in patients with diabetes.Products will be licensed out or partnered to pharmaceutical companies who have an established commercial track record and presence for distribution, sales and marketing in all or selected geographic or therapeutic areas.
-
Headquarters:1201 Market Street Suite 701, Wilmington, Delaware, United States
More -
Phone Number: +1 302-288-0620
-
Website: https://www.curedm.com
-
Employees:3
-
Revenue:$1 - 10M
-
Legal Name:Curedm
-
Curedm's Social Media
-
Is this data correct?
-
| NAICS Code: 621111 |
Show More
Frequently Asked Questions regarding Curedm
-
Where are Curedm's Headquarters?
Curedm's Headquarters are in 1201 Market Street Suite 701,Wilmington,Delaware,United States
-
What is Curedm's phone number?
Curedm's phone number is +1 302-288-0620
-
What is Curedm's official website?
Curedm's official website is https://www.curedm.com
-
What is Curedm's Revenue?
Curedm's revenue is $1 - 10M
-
What is Curedm's NAICS code?
Curedm's NAICS code is 621111
-
How many employees are working in Curedm
Curedm has 3 employees
-
What is Curedm's Industry?
Curedm is in the industry of Biotechnology
-
Who is Curedm's Director Of Development?
Curedm's Director Of Development is Donna Morrow

